EIF3H and hepatocellular carcinoma: Therefore, our findings have demonstrated that EIF3H is a promising deubiquitinating enzyme of OGT and participated in the progression of HCC through ferroptosis, which provides new insights into clinical diagnosis and drug target exploration of HCC.